StockWatch
·
Pharmaceuticals
Board Meeting2 Sept 2026, 11:20 am

Natural Capsules Approves Revised Preferential Issue Terms

AI Summary

Natural Capsules Ltd's Board of Directors approved revised terms for a preferential issue, including up to 1,12,500 equity shares and 4,50,000 convertible warrants. The issue price for both shares and warrants is set at ₹178 per unit. The issuance is directed towards the promoter/promoter group, with Mr. Sunil L Mundra identified as the sole investor. The company also approved a corrigendum notice for an Extra Ordinary General Meeting scheduled for September 9, 2026. The board meeting was convened on short notice due to the late receipt of a valuation report.

Key Highlights

  • Revised preferential issue of equity shares and warrants approved.
  • Issue price set at ₹178 per equity share and warrant.
  • Total equity shares: 1,12,500; Total warrants: 4,50,000.
  • Mr. Sunil L Mundra is the sole investor in the preferential issue.
  • Corrigendum notice for EGM approved; meeting on Sept 9, 2026.